Skip to content

Primerica PRI Investment Proceeds

Investment Proceeds at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$259.2M-13.0%
Sunoco logo
SunocoSUN
$20M-39.4%
The Trade Desk logo
The Trade DeskTTD
$238.3M+44.3%
MACOM Technology Solutions logo
MACOM Technology SolutionsMTSI
$104.65M-9.1%
Dynatrace logo
DynatraceDT
$39.85M+7.7%
ResMed logo
ResMedRMD
$2.5M

Other financials

Income statement

See full
Revenue$872.7M+8.4%
Gross profit$775.2M+17.3%
Net income$190.1M+12.4%
EPS (diluted)$5.97+18.2%

Balance sheet

See full
Cash & equivalents$645.8M+3.3%
Total debt$48.4M-8.6%
Total equity$2.5B+11.7%
Total assets$14.7B+0.6%

Cash flow

See full
Operating cash flow$156.8M-20.6%

Valuation

See full
Market cap$8.79B-16.2%
Enterprise value$8.19B-17.5%
P/E11.4×-9.5×
P/S2.6×-0.7×

Profitability

See full
Gross margin98.1%+0.2pp
Net margin23%+7.1pp

Returns & leverage

See full
Return on equity32.3%+9.8pp
Debt / equity0.0×

Where this comes from

Reported directly by Primerica in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt.

The official record: Primerica’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Primerica's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Primerica's investment proceeds?
Primerica (PRI) reported investment proceeds of $1.99M in Q1 2026.
How has Primerica's investment proceeds changed year-over-year?
Primerica's investment proceeds increased by 61.8% year-over-year, from $1.23M to $1.99M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.